Wintrust Investments’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $89K | Sell |
1,119
-929
| -45% | -$80.4K | 0.08% | 177 |
|
|
2024
Q3 | $184K | Sell |
2,048
-20,596
| -91% | -$1.73M | 0.14% | 142 |
|
|
2024
Q2 | $1.78M | Buy |
22,644
+1,358
| +6% | +$111K | 0.15% | 132 |
|
|
2024
Q1 | $1.85M | Buy |
21,286
+4,572
| +27% | +$390K | 0.16% | 131 |
|
|
2023
Q4 | $1.38M | Sell |
16,714
-7,458
| -31% | -$568K | 0.13% | 149 |
|
|
2023
Q3 | $1.89M | Sell |
24,172
-19,356
| -44% | -$1.62M | 0.2% | 106 |
|
|
2023
Q2 | $3.83M | Buy |
+43,528
| New | +$3.75M | 0.38% | 52 |
|
|
2023
Q1 | – | Sell |
-5,940
| Closed | -$462K | – | 366 |
|
|
2022
Q4 | $462K | Sell |
5,940
-1,779
| -23% | -$144K | 0.06% | 225 |
|
|
2022
Q3 | $623K | Sell |
7,719
-702
| -8% | -$63.1K | 0.08% | 194 |
|
|
2022
Q2 | $756K | Buy |
8,421
+335
| +4% | +$33.9K | 0.09% | 173 |
|
|
2022
Q1 | $897K | Buy |
8,086
+773
| +11% | +$81.7K | 0.09% | 181 |
|
|
2021
Q4 | $757K | Buy |
+7,313
| New | +$847K | 0.07% | 206 |
|
|
2021
Q3 | – | Sell |
-5,913
| Closed | -$734K | – | 359 |
|
|
2021
Q2 | $734K | Buy |
5,913
+170
| +3% | +$21.3K | 0.08% | 205 |
|
|
2021
Q1 | $678K | Buy |
+5,743
| New | +$673K | 0.07% | 220 |
|
|
2020
Q4 | – | Sell |
-5,813
| Closed | -$604K | – | 293 |
|
|
2020
Q3 | $604K | Sell |
5,813
-1,921
| -25% | -$193K | 0.08% | 172 |
|
|
2020
Q2 | $709K | Buy |
7,734
+2,030
| +36% | +$195K | 0.1% | 152 |
|
|
2020
Q1 | $514K | Buy |
5,704
+154
| +3% | +$16.4K | 0.08% | 165 |
|
|
2019
Q4 | $630K | Sell |
5,550
-315
| -5% | -$34.6K | 0.09% | 176 |
|
|
2019
Q3 | $632K | Buy |
5,865
+401
| +7% | +$41.8K | 0.09% | 174 |
|
|
2019
Q2 | $532K | Sell |
5,464
-483
| -8% | -$44.1K | 0.08% | 192 |
|
|
2019
Q1 | $542K | Buy |
5,947
+176
| +3% | +$15.8K | 0.09% | 191 |
|
|
2018
Q4 | $525K | Buy |
5,771
+630
| +12% | +$58.9K | 0.1% | 176 |
|
|
2018
Q3 | $506K | Sell |
5,141
-197
| -4% | -$18.2K | 0.08% | 216 |
|
|
2018
Q2 | $457K | Buy |
5,338
+1,329
| +33% | +$111K | 0.08% | 220 |
|
|
2018
Q1 | $322K | Buy |
4,009
+28
| +0.7% | +$2.31K | 0.08% | 188 |
|
|
2017
Q4 | $321K | Buy |
3,981
+178
| +5% | +$14.3K | 0.07% | 219 |
|
|
2017
Q3 | $296K | Sell |
3,803
-598
| -14% | -$49.6K | 0.07% | 225 |
|
|
2017
Q2 | $391K | Buy |
4,401
+187
| +4% | +$15.8K | 0.1% | 195 |
|
|
2017
Q1 | $339K | Buy |
4,214
+1,010
| +32% | +$78.9K | 0.1% | 211 |
|
|
2016
Q4 | $228K | Buy |
+3,204
| New | +$252K | 0.09% | 187 |
|
Other funds holding MDT
Wintrust Investments's MDT Position: Q4 2024 in Review
Wintrust Investments reduced its Medtronic (MDT) stake by 45% in Q4 2024, selling an estimated $80.4K and leaving 1,119 shares worth $89K. The position accounts for 0.08% of the portfolio, ranked #177.
Wintrust Investments first reported a position in MDT in Q4 2016 and has held it in 30 quarters since. The position peaked at $3.83M in Q2 2023. 2,124 funds tracked by Wall St. Rank hold MDT as of Q4 2024.
- Wintrust Investments held 1,119 shares of Medtronic worth $89K as of Q4 2024.
- Wintrust Investments sold 929 Medtronic shares in Q4 2024, an estimated $80.4K.
- Medtronic made up 0.08% of Wintrust Investments's portfolio in Q4 2024, its #177 holding.
- Wintrust Investments first reported a position in Medtronic in Q4 2016 and has held it in 30 quarters since.
- Wintrust Investments's Medtronic position peaked at $3.83M in Q2 2023.
- 2,124 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.
Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.